About

Molecular Health analyses the molecular and clinical data of individual patients against the world’s medical, biological, and pharmacological knowledge, to drive more precise diagnostic, therapeutic, and drug safety decisions. Taking charge of the extremely complicated legal requirements for such a forward-thinking business in a heavily-regulated sector is general counsel Michael H. Ghaffar, in place since July 2016. Prior to working with Molecular Health, Ghaffar was vice president and general counsel at Samsung Europe and also enjoyed an extremely successful private practice career culminating as a partner with DLA Piper.